Tag: SARS-CoV-2
-
A Public Health View on SARS-CoV-2 Evolution and Surveillance in Germany (2020–2023)
Introduction The SARS-CoV-2 pandemic forced Germany to rapidly adapt its public health framework, shifting from reactive measures to proactive genomic surveillance and data-driven decisions. Between 2020 and 2023, the country faced multiple waves driven by evolving variants, each demanding improved monitoring, testing, vaccination strategies, and international collaboration. This article reviews how the virus evolved in…
-
Public Health Perspectives on SARS-CoV-2 Evolution and Surveillance in Germany (2020–2023)
Introduction: A Public Health Lens on SARS-CoV-2 in Germany From the first biomarkers of SARS-CoV-2 to the rapid deployment of genomic surveillance, Germany’s public health response between 2020 and 2023 provides a case study in how a high-income nation navigates viral evolution, data sharing, and adaptive surveillance. This overview highlights how Germany tracked mutations, integrated…
-
Public Health Perspective on SARS-CoV-2 Evolution and Surveillance in Germany, 2020–2023
Introduction The SARS-CoV-2 pandemic prompted unprecedented public health action across Germany, with an evolving understanding of viral evolution and a rapid expansion of surveillance systems. From the first cases in 2020 through the emergence of multiple Omicron sublineages in 2022–2023, Germany implemented a multi-layered approach to monitor SARS-CoV-2 evolution, detect variants of concern, and inform…
-
Azelastine Nasal Spray: A Potential Shield Against COVID-19 and Rhinovirus
Introduction: A Promising Approach in Respiratory Virus Prevention Azelastine nasal spray, long used to treat allergic rhinitis, is being explored as a potential preventive tool against respiratory viruses, including SARS-CoV-2. Recent findings from a phase II randomized trial published in JAMA Internal Medicine indicate that intranasal azelastine may lower the rate of SARS-CoV-2 infections and…
-
Molecular Basis of Long COVID Brain Fog Revealed by AMPAR PET Imaging
Groundbreaking findings illuminate the biology of Long COVID brain fog In a landmark study led by Professor Takuya Takahashi at Yokohama City University, researchers used a novel PET imaging approach to visualize AMPA receptors (AMPARs) in living brains. The team compared 30 patients suffering from Long COVID with 80 healthy controls and found a systemic…
-
Data Sought for Dec. 2025 COVID Vaccine Antigen Talks
Overview of the December 2025 TAG-CO-VAC Deliberations The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to monitor the genetic and antigenic evolution of SARS-CoV-2, how the immune system responds to infection and vaccination, and how vaccines perform against circulating variants. Ahead of the December 2025 decision-making meeting, TAG-CO-VAC outlines the…
-
Frankenstein Covid Variant XFG Stratus: What We Know Now
Frankenstein variant XFG Stratus: the basics A new SARS-CoV-2 lineage is drawing attention from health authorities as it circulates around the world. Officially labeled XFG and sometimes referred to as Stratus by surveillance networks, the so‑called Frankenstein nickname stems from its recombinant origin. Scientists say the variant appears to result from the recombination of multiple…
-
Frankenstein Covid Variant XFG Stratus: What You Need to Know
A new Covid-19 variant on the radar Public health officials are monitoring a recently identified Covid-19 variant designated XFG Stratus, with the media nickname Frankenstein due to its recombinant origins. The World Health Organization (WHO) has placed XFG Stratus under close observation as its share of infections grows in several regions. In France, Santé publique…